2026 NPPES data Oncology Pharmacist NPI 1740340231
Verify on CMS →

MOJDEH BAUDRY

Oncology Pharmacist in ANAHEIM, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
17
Medicare Part D claims · Oncology Pharmacist avg: 160
What the federal data reveals: MOJDEH BAUDRY is a Oncology Pharmacist ([object Object]) practicing in ANAHEIM, California with a Medicare Part D prescribing footprint of 17 claims .

What stands out: MOJDEH BAUDRY filed 17 Medicare Part D claims in 2023 across ANAHEIM, California. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

MOJDEH BAUDRY at a glance

Quality data not reported

NPI registry status

Active

Issued 12/12/2006

NPI 1740340231

Primary specialty

Oncology Pharmacist

Niche

1,699 US NPIs in this specialty

Medicare Part D claims

17 89% vs specialty avg

2023 prescription claims

Specialty avg: 160

Specialty distribution in California

How Oncology Pharmacist compares to other specialties among California providers

California providers

Oncology Pharmacist share within California

1. Oncology Pharmacist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Oncology Pharmacist share within California

Specialty board-certification context

Estimated specialty board-certified rate — Oncology Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Oncology Pharmacist ABMS/AOA estimate

Est. board-certified rate (Oncology Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Oncology Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MOJDEH BAUDRY is a Oncology Pharmacist provider practicing in ANAHEIM, California, according to the CMS National Plan and Provider Enumeration System (NPPES). NPI: 1740340231. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MOJDEH BAUDRY appears in the CMS NPPES registry as a Oncology Pharmacist provider at 411 N LAKEVIEW AVE, ANAHEIM, CA, 92807, with a listed phone of (714) 279-4026. NPI 1740340231 was issued on 12/12/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BAUDRY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 17 prescription claims written by this provider, covering N/A Medicare beneficiaries and totaling roughly $156 in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Oncology Pharmacist is a narrow specialty nationwide, with 1,699 enrolled providers across 50 states and an average of 160 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

411 N LAKEVIEW AVE
ANAHEIM, CA 92807

Provider Details

NPI 1740340231
Specialty Oncology Pharmacist
Gender Female
NPI Issued 12/12/2006

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to MOJDEH BAUDRY. To verify MOJDEH BAUDRY's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

17
Total Claims
$156
Total Drug Cost
N/A
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
17
Total Day Supply
147
Brand Drug Cost
$0
Generic Drug Cost
$156

Patient Demographics

Average Patient Age
72.3 years
Avg HCC Risk Score
1.48

Oncology Pharmacist Overview

How MOJDEH BAUDRY fits within the Oncology Pharmacist landscape nationally.

1,699
Oncology Pharmacist Providers in US
50
States with Oncology Pharmacist
160
Avg Claims per Provider

MOJDEH BAUDRY's 17 claims are below the specialty average of 160.

Nearby Oncology Pharmacist Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as BAUDRY.

Compare Oncology Pharmacist nationally: see state-by-state distribution →

Frequently Asked Questions

What is MOJDEH BAUDRY's specialty?
MOJDEH BAUDRY specializes in Oncology Pharmacist and practices in ANAHEIM, California.
How much does MOJDEH BAUDRY prescribe under Medicare Part D?
In 2023, MOJDEH BAUDRY wrote 17 Medicare Part D claims totaling $156 in drug costs for N/A beneficiaries.
Where is MOJDEH BAUDRY located?
MOJDEH BAUDRY is located at 411 N LAKEVIEW AVE, ANAHEIM, CA, 92807. Phone: (714) 279-4026.
What is MOJDEH BAUDRY's NPI number?
MOJDEH BAUDRY's National Provider Identifier (NPI) is 1740340231, issued on 12/12/2006.
How many Oncology Pharmacist providers are there in the US?
There are 1,699 Oncology Pharmacist providers across 50 states in the US. The average Oncology Pharmacist provider writes 160 Medicare Part D claims per year.
Does MOJDEH BAUDRY accept Medicare?
MOJDEH BAUDRY appears in CMS Medicare data with 17 Part D claims and N/A Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MOJDEH BAUDRY's credentials?
MOJDEH BAUDRY's NPI is 1740340231. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology